Truist Securities Maintains Buy on Ardent Health, Lowers Price Target to $12
Ardent Health, Inc.
Ardent Health, Inc. ARDT | 0.00 |
Truist Securities analyst David Macdonald maintains Ardent Health (NYSE:
ARDT) with a Buy and lowers the price target from $13 to $12.
